Pillar 6 Overview · Governance

About Safe Infusion Therapy Initiative

An independent, peer-reviewed clinical authority committed to eliminating preventable vascular access injuries, advancing parenteral medication safety, and translating complex pharmacology into actionable bedside guidance.

Clinical Peer Review: Sarah Jenkins, MSN, RN, CRNI, VA-BC Published: October 2026 Verified Board Member →

1. Our Clinical Mission & Values

The Safe Infusion Therapy Initiative was founded to bridge the critical gap between academic pharmacotherapy literature and frontline bedside clinical practice. Intravenous infusion therapy is delivered millions of times each day, yet complications such as extravasation, catheter bloodstream infections, and particulate contamination continue to inflict preventable suffering on patients.

We unite oncology physicians, certified infusion nurses, and sterile compounding pharmacists to deliver open-access, evidence-based clinical monographs and bedside tools that protect human life.

Multi-Disciplinary Board

Medical Review Board

Meet our board-certified clinical reviewers: Sarah Jenkins (CRNI), Arthur Vance (MD Oncology), and Marcus Finch (PharmD BCSCP).

Evidence Rigor · GRADE

Editorial & Review Policy

Explore our 5-stage clinical review workflow, GRADE evidence grading criteria, conflict-of-interest disclosures, and annual review cycles.

Clinical Practice Boundary Notice

This protocol provides evidence-based guidance reflecting INS 2024 Standards of Practice and CDC recommendations. Clinical judgment, institutional policy, and patient-specific variables must guide individualized bedside care.